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Hazardous Drug Administration in the Home: Reducing Exposure Risks
A serious health threat may be looming over patients and families fighting cancer as
antineoplastic drug administration shifts from conventional healthcare centers to the home
setting. Without safe handling, storage, and proper waste disposal, hazardous drug (HD)
residues can expose not only family members, but also visitors and the environment (Crickman
& Finnell, 2016). Hazardous drug exposure can potentially alter DNA, impose reproductive
harm, and is toxic to the body’s natural defenses. According to Graeve, McGovern, Arnold and
Polovich (2017), toxic residues may cause acute allergic reactions and other unintended adverse
side effects to caregivers.
Widespread hazardous drug exposure in the home setting has been well-documented
through many years of studying chemotherapy patients and families (Bohlandt, Sverdel, &
Schierl, 2017; Connor, Zock, & Snow, 2016; Rudnitzki & McMahon, 2015; Yuki, Ishida, &
Sekine, 2015). However, safeguards to prevent home residue exposure are lagging, and patient
and family safety in the home remains unmonitored and less understood (Carpenter, Famolaro,
Hassell, Reefer, Robins, & Siegel, 2017). Contributing to the shift in hazardous drug
administration include the rising numbers of patients receiving oral chemotherapy (Polovich &
Olsen, 2018). Oral chemotherapy is effective and may be considered a more desirable route by
patients over other similar cancer treatment options, but these drugs require the same safe
handling as HDs in other formulations (Lester, 2012).
This large not-for-profit home care agency is located in Northern California and is an
extension of a large hospital system serving the Sacramento region. Services include home
health, palliative care, hospice care, and infusion (IV) therapy. The microsystem provides short-
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term acute and chronic disease management for patients recently discharged from a hospital for a
myriad of health issues. The project will focus on providing home care nurses with the training
and tools required to minimize personal exposure to hazardous drugs in a home setting.
The home health care (HHC) industry is adjusting to the influx of patients receiving oral
and IV hazardous drug agents in the home and recognize the growing need to address employee
occupational safety and health risks. The population in this microsystem include patients who are
receiving infusion therapies such as antibiotics, blood products, chemotherapy, total parenteral
nutrition (TPN), hydration, inotropes, and intravenous pain management. Cancer patients may
require some or all of these infusions during the course of cancer treatment. Oral chemotherapy
adds to the complexity of caring for patients who have additional comorbidities that complicate
care. Home care infusion nurses are struggling to comprehend the importance of their increasing
role and responsibility regarding HD identification, education, and personal safety precautions
required for themselves and families of cancer patients.
The team consists of one team leader, two home infusion coordinators, and 10 to 12
registered nurses. Each nurse has a caseload of up to 20 patients, visiting four to five patients per
day. Six nurses are Certified Registered Nurses in Infusion Therapy (CRNI). Nursing experience
ranges from 4 years to 25 years. The average patient census for the team ranges from 100 to 150,
and the average patient age ranges from 45 to 75 years.
Clinical Leadership Theme
The project aims to improve the confidence, competence, and compliance of home care
nurses’ use of personal protective equipment (PPE) when administering HDs in the home. The
clinical nurse leadership theme that correlates to this project is safety with HD PPE practice.
According to the American Association of Colleges of Nursing (2013), the CNL role of
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“Educator” uses the most current, evidence-based research to teach those persons within the
microsystem. The CNL role of “Systems Analyst/Risk Anticipator” monitors the microsystem’s
operations in order to anticipate potential problems and make corrections to improve processes
that put nurses and families at risk.
Statement of the Problem
The U.S. Bureau of Labor Statistics (2015) reported over eight million health care
workers in the United States are potentially exposed to HD residues, emphasizing current safe
handling precautions and oversight are inadequate. Safe-handling procedures were structured for
application in controlled healthcare environments and are sometimes not realistic in the home
setting. The commonality is that both settings struggle with environmental exposure, noncompliance with PPE, and waste disposal practices (He, Mendelsohn-Victor, McCullagh, &
Friese, 2017). In response to increasing pressures from healthcare professionals, the U.S.
Pharmacopeia Convention (USP, [2016]) General Chapter <800> Standards for hazardous drug
handling and enforcement were developed and will be enforced beginning December 1, 2019.
The standards will require all health care organizations to have hazardous drug management
programs in place or suffer imposed fines or suspended licensure consequences.
Little emphasis has been placed on self-protection strategies for nurses in the home setting,
and most are unaware of the increasing dangers of exposure. One major concern is the
unavailability of hazardous drug PPE for home care nurses. Other issues include (1) fragmented
patient health information, (2) incomplete medication records, (3) work productivity pressures,
(4) and outdated policies. Evidence-based HD education and innovative learning activities are
lacking because of budgetary constraints and access to oncology content experts. However, safe
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drug handling should be a top priority because any level of HD exposure is unacceptable
(Diamond, 2017).
Project Overview
Safety and advocacy are important core values of the CNL’s role and are the basis for this
evidence-based project. With organizational support, home care nurses will become better safety
advocates, not only for patients and families, but for their colleagues that follow. The CNL’s
objectives aim to (1) improve nurses’ knowledge of hazardous drugs, (2) improve compliance
with PPE use in the home, (3) provide nurses with HD PPE and (4) develop a quick reference
guide for reporting an exposure. Finally, a “Hazardous Drug Safe Handling Guide” for patients
and families will describe actions to minimize personal and home exposure.
To accomplish best practices, the global project aims to improve safe handling from 39%
to 95% by implementing two home care nurse educational sessions; (1) recognizing and
responding to HD exposure in the home, and (2) providing a hands-on PPE competency training
no later than March 15, 2018. The specific aim is aligned with the global aim of providing a
residue-free home environment for everyone. The global and specific aims are united and both
create a sense of urgency with a definite purpose, expected outcomes, and time frame for
sustaining results.
The project begins with (1) surveying home care nurses to determine knowledge, beliefs,
and attitudes about hazardous drug exposure risks, and (2) understanding current comfort levels
and experience with personal protective equipment (PPE), with the aim of minimizing hazardous
drug exposure during a home visit. The process ends with enhanced organizational support for
home care nurses by providing HD education and supplying the necessary PPE by March 15,
2018. It is important to work on this project now because the known adverse health and
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environmental risks are valid, and new hazardous drug regulations mandate and support an
efficient, standardized approach.
Methodology
The organization uses a performance improvement real-time data collection program
called Strategic Healthcare Programs (SHP). This program provides analytics, benchmarks, and
dashboards for home care agencies across the country. The data collection is intended as a guide
to help improve quality and optimize performance for home health care agencies, hospices and
home infusion pharmacies. The data also helps the organization maximize reimbursement for
patient care and helps improve compliance with the Centers for Medicare and Medicaid (CMS)
requirements specific to home health care participation. This program is a good resource for
CNL’s because SHP reports highlight areas where staff education and professional oversight
should be focused to improve patient satisfaction and health outcome scores.
Strategic Health Programs (SHP) data identified that from January 1, 2017 through
December 2017, 440 patients were admitted with a primary or secondary cancer diagnosis to the
microsystem. However, data mining for information was cumbersome and incomplete in
determining the current census of patients receiving hazardous drugs. Without the ability to
accurately identify patients on service who are prescribed these medications, the risk of exposure
is even more alarming. More work needs to be done with internal and external informatics
specialists to capture this population’s data, perhaps through specific ICD-10 coding or HD
medication list alerts in the future.
Rationale
Several methods of evaluating information to identify the specific needs of the project
included (1) performing a root cause analysis, (2) home care nurse surveys at the annual skills
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day competency fair, and (3) completing a SWOT (Strengths, Weaknesses, Opportunities, and
Threats) analysis. The root cause analysis (see Appendix A) identified outdated policies
addressing HD management, inadequate and unavailable PPE, and a lack of evidence-based
resources to support clinicians in teaching families how to minimize exposure with HD
administration.
The nurse surveys from the competency fair in January 2018 provided good data on
several fronts (see Appendix B). When nurses were asked about the risks associated with
hazardous drug administration to test for “knowledge of the hazard”, 25% felt that oral
chemotherapy was safer to administer than other routes. Fifty-one percent of nurses perceived
personal home exposure risks as highly likely, but over 30% felt it was unlikely. When
evaluating workplace safety, 79% of nurses assumed that the organization had a HD policy
which was not the case (see Appendix B).
When assessing knowledge and experience with PPE use in the home, 75% of nurses
admitted to having little to none. Nurses expressed hesitation to don PPE because it may cause
patient or family anxiety. Nurses rationalized that it would take longer to don PPE than it would
to “hand a pill to the patient”. While this may be true, unsafe handling place everyone at risk and
sets the stage for potential adverse results. With new advances in science and technology,
patients are performing tasks originally done by trained nurses. However, it does not negate the
responsibility of nurses to supervise and support patients performing those tasks.
The SWOT analysis (see Appendix C) clarified the overwhelming need for the
organization to address HD exposure now to prepare for upcoming enforceable worker
protection regulations by federal, CMS, state and other credentialing entities expected in 2019.
The analysis also highlighted the weaknesses and vulnerabilities of home care clinicians in
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regards to the lack of knowledge about antineoplastic administration and the beliefs that
exposure risks were low or non-existent in the home setting. Other weaknesses identified were
operational issues with informatics and application software used by nurses to access and
document patient care. Opportunities to improve family and home care nurse safety through the
application of best practices with safe handling and PPE use are within reach and are worthy
goals of this CNL project.
Cost Analysis
The project required a solid organizational hazardous drug program framework that was
missing. As a consequence, it took the senior management team six months to initiate a few
temporary fixes to protect nurses until a comprehensive HD program could be implemented.
Portions of the USP <800> Standards were chosen as the developing framework in the
microsystem (see Appendix D). Budget projections (see Appendix E) lists the items and
estimates required to comply with those standards. A CNL will be essential in developing each
piece of the framework to ensure effective use of resources and minimize costs. It will take 12
months for the program to be fully integrated into the microsystem. After the program is fully
sustainable, the CNL could refocus on other important safety and quality issues.
An education module would be added to new hire and annual competency training
through the “HealthStream” on-line learning system. A customized PPE kit would be available in
the office for nursing to obtain for patients requiring these items. A personal PPE kit for car
stock would cost the organization around $16.00 per nurse, however, individual items such as
gloves and plastic-backed pads, could be restocked separately. The overall costs over two years
is around $300,000. By implementing competency training and providing PPE, this project will
improve the safety of nurses and families by 95% no later than March 30, 2018.
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The risk to the organization will also be reduced in regards to occupational health claims
due to HD exposure. According to the Worker’s Compensation Insurance Rating Board, the
2017 average California indemnity claim averaged $37, 054 which was the 5th highest-reported
claims cost in the United States (WCIRB, 2017). This average claim is 40% higher than the
median average nationwide. With this cost risk in mind, and applying it to ten exposed nurses,
the cost for one year would be over $370,540 per year. The average California claim is reported
as paid over three years at a cost of $1.1 million dollars for 10 potential nurse exposures.
Change Theory
Kotter’s change theory will be used to implement an evidence-based quality improvement
project that addresses HD safety for home care nurses as described in Appendix F (Kotter &
Cohen, 2002). The model was chosen because it intends to promote behavioral change (Frieson,
Foote, & Wagner, 2012). The 8-step model will help the microsystem and organization complete
the changes necessary to provide nurses, and patients and families, with a safer work and home
environment with hazardous drug administration. This is the perfect time to implement this
project because healthcare organizations are preparing for the 2019 enforcement deadline, and
home care agencies will not be exempt from the USP <800> Standards and regulations outlined
for patient and worker safety.
Kotter’s 8-step change theory stresses when people connect emotions with a desired
change, the change is more apt to be effective and sustainable. With improved knowledge and
awareness of exposure hazards, nurses are more apt to practice safe handling to protect
themselves, patients and families. The steps to accomplish the desired change include; (1)
assuring everyone understands the sense of urgency, (2) forming a powerful, interdisciplinary,
guiding coalition, (3) creating a common vision, (4) communicating the vision of what the future
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would look like, (5) empowering others to share the vision, (6) planning for, and creating shortterm wins that create momentum, (7) removing the negative resistance, not letting up, and (8)
making it stick.
Data Source/Literature Review
The PICO statement used to find literature to support the project was “With the
increasing risk of HD exposure to (P) home care nurses, patients and families, and the
environment, what is the effect of a (I) hands-on PPE nursing in-service compared to (C) no inservice on the level of (O) nursing compliance with PPE use?” Key words for the PICO question
included hazardous drug, health care workers, personal protective equipment, safe-handling, and
chemotherapy. Numerous articles were available to support the PICO question regarding
healthcare workers (those employed in controlled-health settings) but few specific to home care
workers.
After careful literature review, and advanced searches in CINAHL and PubMed
databases, 11 articles with dates that ranged from 2012 to 2017 were selected for review. The
articles in the review were evaluated for evidence and quality using the Johns Hopkins Nursing
Evidence-Based practice tool. Four of the 11 articles chosen were rated Level IV and good
quality. The results of the studies selected provided consistent evidence related to HD exposure
risks and PPE requirements. The strengths and limitations of the Level IV literature indicated the
need for further research on home environmental contamination and long-term health effects
with chronic residue exposure.
Bohlandt, Sverdel, and Schierl (2017) conducted an environmental and biological study
with the aim of confirming HD residues on common household surfaces inside 13 homes of
ambulatory patients receiving outpatient chemotherapy and determine whether HD levels could
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be detected in the urine of persons residing in the home. There were 13 study participants who
received intravenous chemotherapy in an outpatient clinic. Two-hundred and sixty-five wipe test
samples were taken from home surfaces, including toilet, bathroom, and kitchen, and 62 urine
specimens from patients and families were collected. Every surface tested had significant levels
of HD residues. However, there were no traceable residues found in the urine of family
members. This research study concluded that strict hand hygiene measures and PPE are
necessary to ensure a safer home environment, free from hazardous drug residues. The research
also confirmed that the patient’s urine post-chemotherapy was the main source of contamination
inside the home. The evidence presented in the article was a Level IV and of good quality.
Another study by Yuki, Ishida, and Sekine (2015) measured urinary hazardous drug
excretion by patients and family members at home. Eight patients treated with
cyclophosphamide (CP), 10 family members, and ten control patients provided urine samples
over seven days. One hundred twelve of 276 urine samples from patients detected CP five days
after treatment. Fifty-two of 243 urine specimens from family members had detectable levels of
CP. The long-term effects of low-dose HD exposure are not well-understood. Furthermore, the
researchers stressed the need to develop consistent home safety measures to protect patients and
families. Even though the study was limited in size, the results were significant and confirmed
through scientific analysis. The evidence presented was also a Level IV and of good quality.
Eisenberg (2015) argued the need to change workplace culture regarding HD safety
precautions, implement current guidelines, and resolve misunderstandings that exposure risks are
minimal. The author asserts that current guidelines and research to support stronger prevention
programs, including enforcement, will lead to better results. The USP <800> Standards were
reviewed as it relates to state legislative involvement and The Joint Commission (TJC)
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enforcement implications on healthcare organizations, however, home care enforcement was not
mentioned.
Dike, Ogunmakin, Pokluda, Shank, Yates, and Payne (2014) argue that while home HD
self- administration might be convenient for patients and families, these drugs require the same
safe handling to avoid secondary exposure. Home care nurses will require PPE and access to
chemotherapy spill kits. However, kits may need to be modified to apply to some unique home
exposure situations. The CNL project has addressed this issue and intends to ensure that nurses
have the proper PPE and training necessary to provide better barrier protection and safer care.
An international pharmacy panel collaboratively acknowledged the increase in oral
chemotherapy practices and the issues surrounding safe handling and waste disposal of toxic
medications outside of a controlled environment. Patients and families are now preparing and
administering HDs and potential exposure risks have increased. The panel expressed concerns
that the attitudes and beliefs of healthcare workers may influence the behaviors of families by
downplaying exposure risk to oral HDs by indicating that personal protection is unnecessary.
International roundtables led to discussions about storage, handling, patient and worker safety,
and the need to standardize practices specific to each organization’s need to protect healthcare
workers and the public (Goodin, Griffith, Chen, Chuk, Daouphars, Doreau, C., . . . Meier, 2011).
Likewise, Lester (2012) provided an overview of evidenced-based literature that supports
the importance of ensuring that all healthcare workers are educated on applying the same
principles of HD management with oral agents as with other methods of administration. The
author recommended that healthcare workers should be instructed to monitor patients for
adherence and compliance to safe administration practices to ensure they receive the optimal
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benefits. The author recommended that proper education and competencies with PPE include
patients and families.
Rudnitzki and McMahon (2015) conducted a systematic review of the literature from
2003 to 2014 with the aim of understanding the implications for nursing practice related to the
shift in responsibility to patients and families regarding hazardous drug administration.
Unintentional exposure to family members, medication errors, and unaddressed toxicity concerns
and environmental pollution were among some of the identified risks associated with HD selfadministration without professional oversight. The false impression of safety with oral
chemotherapy versus intravenous routes indicates that patients may not understand the potential
hazards of oral hazardous drugs. Overall, the authors’ review confirmed patient education and
training were essential to ensure the safety of others.
One prospective-controlled study compared routine instruction to innovative instruction
in nursing students and discovered that more knowledge and practical application skills were
acquired and retained better using an innovative teaching approach. The researchers found that
nursing students lacked understanding that oral chemotherapy was as dangerous as other routes
of HDs and were less inclined to use PPE during administration. A decrease in environmental
contamination was a result of improving nurses’ understanding and skills. When considering the
best method for instruction, this study revealed innovative instruction could be applied to this
project (Zimmer, Hartl, Standfuls, Mohn, Bertsche, Frontini, . . . Bersche, 2016).
Crickman and Finnell’s (2015) literature review asserts healthcare workers in multiple
settings may be at risk for HD residue exposure that could lead to adverse health consequences.
Evidence-based PPE and safe-handling recommendations were presented acknowledging
modifications would have to be considered for the home setting. Recommendations ranged from
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improving PPE competency and access, increasing professional oversight and medical
monitoring, standardizing HD identification processes, and implementing a comprehensive HD
program for all home care workers.
Hennessy and Dynan (2014) reported on a PPE initiative conducted at Dana-Farber
Cancer Institute in the ambulatory infusion center. Observations of oncology infusion nurses
revealed a 30-40% compliance rate with PPE use while caring for patients. The project used the
framework for the Model for Improvement which is a continuous process of testing change,
assessing performance, and providing feedback. The importance of this observational study is
that compliance dramatically improved by implementing staff audits, peer review and innovative
learning activities.
The CNL project includes mandatory in-services to improve knowledge and awareness of
HD safety. The process consists of observations of individual nurse competency and compliance
with PPE standards, immediate feedback to encourage best practices, and real-time measurable
performance postings. A safe handling awareness campaign along with conscience raising
activities (lectures and interdisciplinary discussions) will hope to improve PPE competency and
compliance to 95%. Kotter’s change theory will incorporate much of what was done to improve
and sustain the Dana-Farber initiative, as it is more relevant to this project.
Timeline
The project will be completed in phases. “Phase 1” began in September 2017 and will
conclude in April, 2018, however, future phases will continue within the organization through
December 1, 2019 to ensure compliance with the USP <800> Standards. Senior leadership
recognized the need to begin the project in September 2017. From September 2017 to December
15, 2017, organizational processes such as policy review and revisions, education module
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program development, and home PPE items were agreed upon. The Gantt chart (Appendix G)
defined a step-by-step timeline to complete this phase, however, for the purposes of this project,
the timeline began on January 15, 2018 and will end on April 6, 2018.
The first step began with providing an initial survey of 61 homecare and infusion team
(HIT) nurses at the annual skills day competency fair on January 15th, 2018. The purpose of the
survey was to gather data to determine current knowledge, beliefs, attitudes, and behaviors
associated with HD precautions and administration, and on January 16th, the data was reviewed.
Second, a team of oncology nurses began developing several health literacy tools that included
an HD oral administration protocol from January 20st through February 25th. The Oncology
Certified Nurse (OCN) worked with the team as a content expert for the home health division to
create a “Hazardous Drug Home Safety Guide” (see Appendix H) for families and a “Quick PPE
Choice Guide” (see Appendix I) for home care clinicians. Third, a nursing in-service with half
of the home infusion team was done on personal protective equipment training on March 3rd.
Fourth, a home visit was completed with a nurse on March 6th. Fifth, a second in-service was
completed on March 15th with the other half of the nurses. Again, a home visit was arranged
with a nurse on March18th. Sixth, the microsystem was rewarded for its contribution to
developing a culture of safety in the patients’ homes. Seventh, the results were shared with both
nursing groups on March 30th. Eighth, results for phase 1 will be presented to senior leadership
with recommendations to include all homecare divisions in future plans.
Expected Results
With the implementation of a hazardous drug administration program, the leadership
team expects the organization will be compliant with the USP <800> Standards ahead of the
projected mandate of December 1, 2019. Home care clinicians will be more competent and
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inclined to practice safe handling and waste disposal. Personal protection strategies will improve
as 95% of homecare nurses will utilize proper PPE when exposure risk is present. Survey results
from the annual skills day held in January 2018 will be compared to survey results on March 30th
when the nurses regroup, and data will be compared to see if improvements have been realized.
Providing nurses with the education and training with PPE will improve safe handling of
HDs in the home. In addition to improving safety, an HD kit will ultimately be more costeffective to the organization as nurses will be protected from toxic exposure. Patients and
caregivers will feel more confident in managing potential HD spills. The success of this change
process affirms efficient lateral integration and improved patient-nurse partnerships that promote
safe patient-centered care for those requiring hazardous drug administration at home.
As more evidence becomes available on the acute and long-term effects of HD exposure
in the home, nurses will need to take a more proactive approach in reviewing the institutional
policies and workplace environment to ensure feasible evidence-based solutions. Themes that
may emerge from this project include (1) tracking exposed healthcare workers through an
organizational database that is reportable to OSHA, and (2) increasing efforts to enforce
regulations at every level of government. According to Polovich and Olsen (2018), thirty years
of studying the issue has not solved the problem of occupational HD exposure.
Nursing Relevance
The unique nature of providing hazardous drug administration to patients in the home has
posed a new dilemma; keeping clinicians, patients and families, and the environment safe. The
recommendations for safe-handling have remained consistent through the years, nonetheless,
suboptimal PPE use and HD exposure continue to plague the workplace. The home environment
is more complex for HD administration because each home has its own limitations. Personal
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protective equipment, including the recommended type of gloves for oral administration, have
not been available to homecare nurses. This issue underscored the need for organizations to
standardize PPE and ensure nurses are protected when providing patient care in the home.
Furthermore, the Occupational Safety and Health Administration (OSHA) recommends
using a hierarchy of controls to address potential hazardous drug exposures (see Appendix J).
Some of the controls are not feasible in the home. For example, the first control in the hierarchy
is eliminating the source. Patients are prescribed these medications to treat disease, thus,
elimination is impossible. The second control is to replace the HD with an alternative. This too,
would have to be the physician’s decision. The third control would be to isolate persons from the
hazard. This can be done in the home by limiting the number of persons assisting the patient with
drug administration. Nurses could instruct the patient to store and administer the agent in one
area of the home to avoid cross-contamination to surfaces in the home setting. The fourth
control, “changing the way people work”, is an important and practical solution because nurses
can educate and train patients and caregivers to practice good hand hygiene before and after
administration, how to clean-up exposed areas, dispose of hazardous waste, and reporting of
personal contact with agents that have the potential to cause adverse acute and long-term side
effects. The final control in the hierarchy includes protecting workers and families by using
barriers and PPE. This critical step minimizes risks associated with contact. However, PPE
needs to be readily available not only for clinicians, but for families too.
Summary Report
The aim of this evidence-based project “Hazardous Drug Administration in the Home:
Reducing Exposure Risks” was to improve home care nurses’ knowledge and competency
regarding hazardous drug administration and the use of personal protective equipment (PPE) in a
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home setting. The project began in January 2018 and continued through April 6, 2018 in a home
health microsystem of a large community hospital system. The expectations after didactic and
hands-on demonstration sessions geared toward nurses proposed to increase knowledge and
competence from 39% in January 2018 to 95% in April 2015. However, management only
allowed 15 of the 61 homecare nurses to participate in the project. After instruction, only 10 of
15 home infusion nurses expressed comfort with using a chemotherapy spill kit, and 11 of 15
stated they were now familiar with the steps involved in managing a chemotherapy exposure in
the home setting. It is clear that home care nurses will need joint supervisory visits and regular
PPE competency training over time to reach the goal of 95% compliance with PPE. A Hazardous
Drug Administration Safe Handling Checklist will be needed to document initial and annual
compliance, and competency tracking (see Appendix H).
Methods and teaching aides used to implement the project were (1) a power point
presentation on hazardous drug administration, (2) hands-on PPE training session, (3) hazardous
drug administration checklist for clinicians, (4) quick PPE choice guide for clinicians and (5) a
patient and family tool about hazardous drug safety in the home. All of the tools were developed
by the CNL student with the assistance of a health literacy team, oncology nurse experts, and
interprofessional collaboration between hospital nurses, oncology clinic nurses, outpatient and
home infusion pharmacists, and the home health care nursing team. The Chief Nurse Executive
(CNE) was instrumental in streamlining communication with the various home health directors
who provided guidance that influenced the outcomes of the project. However, this expanded the
project well beyond the plans associated with this phase of implementation.
The baseline data collected through nurse questionnaires provided opportunities for
future improvement projects within the microsystem. The data also revealed a serious gap in
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knowledge that places homecare nurses, patients and families, and the environment at risk for
HD exposure. Kotter’s 8-step change theory provided a methodical approach to completing a
small piece of a much larger project that the organization is implementing and was an efficient
way to keep the momentum moving forward when there were unexpected obstacles impeding
progress.
The interdisciplinary coordination and collaboration between hospital oncology nurses,
oncology clinic nurses, and home care nurses during this project provided an excellent learning
opportunity for each professional group. It was important that patient education be consistent
throughout the continuum of care and that all nurses follow the same hazardous drug precautions
in every patient encounter, no matter the site. Moreover, the project demonstrated a need for
greater understanding of the complexities of HD administration in the home and the need to
provide training and education to reduce risk from exposure to hazardous drug residues.
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Appendix A
Nurse Questionnaire Responses
61 nurses participated in the survey at the Annual Skills Day and Competency Fair at the
Sacramento Homecare Branch.
Question 1: (Knowledge of the hazard)
1. Do you think that oral chemotherapy/hazardous drug administration (HDs) is safer than
intravenous (IV) administration of chemotherapy/HDs for nurses in the home?
A. Yes, oral chemotherapy administration is safer than intravenous (IV) chemotherapy
administration for nurses in the home. (25%)
B. No, I think oral chemotherapy administration is just as unsafe as IV chemotherapy.
(39%)
C. I don’t know which method of administration is safer for nurses in the home. (36%
Response: 15 nurses answered “A”. 24 nurses answered “B”. 22 nurses answered “C”. The
majority of nurses know that oral chemotherapy is as unsafe as IV administration in the home,
but they don’t know which method would be safer. (Actually, both routes require the same safehandling requirements to protect themselves, patients and families, and the environment.
Although it may be simpler to administer oral chemotherapy, personal protection considerations
are warranted).
Question 2: (Perceived Risk)
2. How likely are you to be exposed to someone in the home receiving oral or IV
chemotherapy?
A. Never (3%)
B. Unlikely (30%)
C. Likely (16%)
D. Highly Likely (51%)
Response: 2 nurses answered “A”, 18 nurses answered “B”. 31 nurses answered “C”, and 10
nurses answered “D”. (Nurses perceptions are that it is likely that someone in the home could be
receiving or IV chemo and that they could be potentially exposed in the home setting.
Widespread contamination of HD residues in the home have been well-documented inside the
patient homes who receive chemotherapy or other non-oncology hazardous drugs through
environmental contamination, although oral chemotherapy contamination is less understood).
Question 3: (Workplace safety climate)
3. Do you know where to find information at work about hazardous drug precautions?
A. Yes (79%)
B. No (21%)
Response: 48 nurses answered “Yes”. 13 nurses answered “No”. (The organization does not
have a policy in place for hazardous drug precautions, but nurses have been informed on where
to find such policies in the past. A new policy is being created now for oral chemotherapy
administration in the home setting, and a Hazardous Drug Management program will be rolledout to address the issues).
Question 4: (Interpersonal influence)
4. When you do a medication reconciliation, do you ask patients/family members if they are
taking any chemotherapy/HD via oral, IV, topical, subcutaneous or g-tube routes?
A. Never (16%)
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B. Sometimes (36%)
C. Always (43%)
D. I don’t feel like this question is important to my role in home care. (5%)
Response: 10 nurses answered “A”. 22 nurses answered “B”. 26 nurses answered “C”. 3 nurses
answered “D”. (The Electronic Health Record (HomeCare/HomeBase (HCHB) does not prompt
the nurse to ask questions pertaining to chemotherapy/HD medication and does not alert nurses
who enter these drugs in the patient’s medication record. Efforts are underway with the help of
the HCHB team and the Informatics team to address these problems).
Question 5: (Perceived conflict of interest)
5. How comfortable are you with using a hazardous drug spill kit?
A. Uncomfortable (17%)
B. Comfortable (8%)
C. I have never had the opportunity to demonstrate competency with a hazardous drug
spill kit. (75%)
Response: 10 nurses answered “A”. 5 nurses answered “B”. 46 nurses answered “C”. (This
finding creates an opportunity to teach nurses how to properly apply PPE to prevent personal and
environmental exposure. In addition, a new oral chemotherapy administration kit is being
considered for inclusion into the homecare nurses’ car stock).
Question 6: (Knowledge of the hazard)
6. How familiar are you with the steps involved in managing a chemotherapy exposure in
the home setting?
A. Not familiar (66%)
B. Familiar (18%)
C. I don’t think I would ever need to manage a chemotherapy exposure in the home
setting. (16%)
Response: 40 nurses answered “A”. 11 nurses answered “B”. 10 nurses answered “C”. (Again,
this is an opportunity to educate nurses on the steps required to manage a hazardous drug
exposure, including; safe handling, containment, storage and waste disposal of contaminated
surfaces, and reporting process).
Question 7: (Self-efficacy)
7. I am familiar with the NIOSH List of antineoplastic and other hazardous drugs (2016)
reference tool.
A. No (51%)
B. Yes (19%)
C. I have no idea what the list is or how it relates to my role in the home. (29%)
Response: 31 nurses answered “A”. 12 nurses answered “B”. 18 nurses answered “C”. (The
NIOSH list has the most recent hazardous drug list and the required personal protective
equipment required to protect healthcare workers. This list may be added to the homecare nurses’
tablet for quick reference).

Running Head: HAZARDOUS DRUG ADMINISTRATION

26

Home Visit #1
Patient Information: 69 y/o male with history of acute on chronic respiratory failure due to
recurrent aspiration pneumonia (pseudomonas), malnutrition with tube feeding, history of nonHodgkin’s lymphoma in 2001, head and neck cancer with dysphagia requiring PEG tube feeding,
CAD with stroke, chronic stridor, advanced lung cancer, admitted to homecare services with IV
needs (Zosyn 4.5grams every 6 hours via CADD SOLIS infusion pump for 5 days).
Assessment: CNL student, also an Oncology Certified Nurse (OCN), assisted home RN with
medication review and noted that patient was taking an oral antineoplastic medication daily
(Tagrisso/Osimertinib) for the treatment of advanced lung cancer. Patient’s wife stated that she
was dissolving the tablet in a small cup and pouring the liquid into a 60 mL syringe to drain into
the PEG tube. Patient has chronic diarrhea, and the linens were visibly soiled. RN notified the
MD office that patient was unable to swallow and was ingesting the medication via PEG and had
diarrhea, which may a side effect of the oral chemotherapy drug. The CNL student informed the
physician that the medication should be administered via a closed-system transfer device that fits
into the PEG tube but these are not available outside of a hospital setting. The physician did not
suggest an alternative route for safe drug delivery. The CNL student called the Astra Zeneca
Pharmaceutical Company (manufacturer of Tagrisso) to inquire about alternative routes and PPE
requirements with administration. We were instructed to consult our own organization’s policy
for hazardous oral drug administration. The patient’s wife did not have any PPE, including
gloves, for safe handling. Home nurse was not able to provide any instructions about safe
handling and did not have proper PPE to prevent personal exposure. The CNL spent some time
educating the patient’s wife and provided her with several options for self-protection, such as
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gloves, zip-lock bags, and plastic-backed barriers to reduce personal and environmental
contamination.
Outcome: The CNL student called a meeting with the Sutter Health Oncology Nurse Chapter
(SHON) to share concerns about home administration by untrained caregivers. Several oncology
nurse practitioners and one oncology pharmacist agreed to help push the agenda forward with the
organization. The CNL student also suggested to Astra Zeneca that they place hazardous drug
precautions on their website for patients and families to reference, and remove the statement that
allows the medication to be dissolved in water at home. The rationale given by the manufacturer
was that if the medication were aerosolized with crushing, it may pose a greater danger than
allowing it to dissolve in the water. More needs to be done to ensure safe handling of these HD
agents in the home.
Home Visit #2
Patient Information: 83 y/o female with history of colon cancer with mets to the liver and
lungs. Has ileostomy with generous output/primary caregiver is spouse. Currently receiving TPN
for failure to thrive and ostomy output issues.
Assessment: Joint visit with RN to perform medication reconciliation and provide spouse with
information on the safe handling of Megace. Spouse has been administering this medication
without gloves or other PPE and does not feel the need to start doing it now. He has filled a cup
with the medication at the bedside and has her sip on it every 6 hours. Patient has dementia and
is unable to follow commands but spouse wants to try everything to keep her comfortable.
Outcome: RN notified the office of the potential risks and contamination of the home
environment to this toxic medication and asked patient’s spouse to wear gloves. Information left
for spouse to consider regarding safe storage, administration, and waste disposal.
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Appendix D
USP <800> Requirements
Hazardous Drug
Reference List
Requirement:
Create a facilityspecific list of
hazardous drugs that is
accessible by all staff
(i.e. NIOSH list of
antineoplastic and
other hazardous drugs,
2016).
List must be:
1. Reviewed annually.
2. Updated when
newly approved
hazardous drugs are
incorporated into
the practice setting.

Training
Requirement:
Training must be
provided to all staff
who may have contact
with hazardous drugs
prior to initial work
assignment, and
annually, thereafter.
1. Summary of
policies and
procedures.
2. Proper use of PPE
and other
equipment.
3. Exposure response.
4. Managing
exposures.
5. Disposal of bags,
tubing, syringes,
and PPE.
6. Include oral
chemotherapy
medication
administration,
monitoring,
procurement, and
waste disposal.

Hazardous Drug
Communication Program
Requirement:
1. Establish policies and
procedures to ensure
worker safety.
2. Describe in writing
how the standard will
be implemented.
3. Provide training for all
personnel who may be
exposed to hazardous
drugs prior to handling.
4. Obtain written
confirmation that all
personnel of
reproductive capability
(includes men and
women of childbearing
age), and understand
the risks associated
with hazardous drugs.
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Appendix E
Budget Estimates for Project Implementation
Two Year Projections 2017-2019
Oncology Clinical Nurse Leader 1.0 FTE for 12
months
Health Stream Education Module Development and
update revisions
Staff nurse training/competency testing @ $50.00
per individual x 15 nurses (Home Infusion Team
Champions)
Staff In-service- Hazardous Drug Management in the
Home/ 15 Home Infusion Team Champions
Hazardous Drug Administration and Spill Kits ($30
+ $16 each, respectively for RN car stock)
Staff replacement during training (rule: 1 staff in
training = 1 less patient /visit=1 hour of service
NIOSH List of antineoplastic and other hazardous
drugs 2016 reference guide for clinicians

Year 1
$90,000

Year 2
0

$1500

$1500

$750

$750

$750

$750

$108,790

$108,790

$750

$750

Free

Free

$202,540

$112,540

Cost Benefit Analysis compared to Worker’s Compensation Claims in California 2017
Potential Worker’s Compensation Claims for HD Exposure
for 10 nurses @ $37,054 per year

$370,540

$370,540

Cost of HD management start-up for 15 nurses in homecare

$202,540

$112,540

Cost Savings due to reducing risk of exposure

$168,000

$258,000
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Appendix F
Implementation of Kotter’s 8-Step Change Model
Step 1- Establish a sense of urgency/ Why change now?

Hold convincing conversations about the rising trends in home chemotherapy administration.
Share credible research data on home environmental exposure studies within the last 5 years.
Regulatory enforcement is required by December 1, 2019 through USP <800> standards.
Step 2- Form a powerful guiding coalition/ Who really cares?
Seek out directors of the organizations (i.e. Chief Nursing Executive, Licensure/Accreditation,
Education, Risk Management/Safety, Quality Management, Informatics, Nursing Team Leaders in
Home Health, Infusion, Hospice, Palliative Care programs.
Recruit staff that are invested in the health outcomes of patients and staff.
Step 3- Create a vision and a Strategy/ How do we get there?
Education modules regarding hazardous drug precautions, oral chemo administration at hire, annually.
Staff training on use of PPE, waste disposal, and reporting exposure in the home

Step 4- Communicate the vision of change/How do we share what we know?
Regular safety meetings (quarterly), placing reference tools in Clinical Connect Employee newsletter,
senior leadership push to get the word out in their meetings, email strategies
Step 5- Empower others to act on a vision/ What do we do?
Share ideas throughout the implementation process, and post communication/ideas on boards.
Step 6- Plan for and create short-term wins/ How do we reward successes?
Acknowledgement by senior leadership for great ideas.
Provide CEU’s for learning modules.
Step 7- Consolidate improvement plans and produce more change/How do we work together?
Use SMART objectives to address gaps and barriers, and implement strategies for improvement.
Step 8- Institutionalize new approaches in the culture/ Make it a culture of safety.
Mandatory learning modules at hire, and annually. PPE competencies for all healthcare workers.
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Appendix G
GANTT CHART
Project starts:
January
01/15/2018
2018
Projects Ends:
04/06/2018
1. Annual
Competency
15th+ 16th
Fair Surveys
2. Learning
Module/Health
20th to
Literacy
Tool/PPE
Guide
Development
3. RN in-service
½ nursing staff
4. Home Visit
with RN
5. RN in-service
½ nursing staff
6. Home Visit
with RN
7. Share results
with
nurses/Post 2nd
survey results
8. Share results
with
Leadership

Feb
2018

Mar
2018

Apr
2018

May
2018

June
2018

25th

3rd
6th
15th
18th
30th

6th

Persons Responsible for tasks (CNL +):
1. Director of Education and Nursing Quality

5. Team Leader #2/Homecare RNs

2. Oncology Nurse Committee/Health Literacy Team 6. Homecare RN
3. Team Leader #1/Homecare RNs

7. All Nurses and Team Leaders

4. Homecare RN

8. All Directors
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Quick PPE Choice Guide for Clinicians

How to Report a Hazardous Spill or Occupational Exposure
Notify your supervisor, and complete “Electronic Report of Injury” form located on the SCAH Employee Portal.
Employee Health will contact you for follow-up.
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Hierarchy of Controls
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